S. Tamraz

Macrophage inflammatory protein-1β induces migration and activation of human thymocytes

N. Taylor, T. Schall, K. Franz-Bacon, 1998 .

Treatment of delayed-type hypersensitivity with inhibitors of the VLA-4 integrin

F. Gaeta, T. Arrhenius, M. Forrest, 2004, Springer Seminars in Immunopathology.

Stable IgG-like Bispecific Antibodies Directed toward the Type I Insulin-like Growth Factor Receptor Demonstrate Enhanced Ligand Blockade and Anti-tumor Activity

A. Lugovskoy, Xiufeng Wu, A. Sereno, 2010, The Journal of Biological Chemistry.

Immunosuppressive phenotype of corticotropin-releasing factor transgenic mice is reversed by adrenalectomy.

N. Ling, A. Gaur, E. D. De Souza, 1997, Cellular immunology.

Combination of Two Insulin-Like Growth Factor-I Receptor Inhibitory Antibodies Targeting Distinct Epitopes Leads to an Enhanced Antitumor Response

A. Sereno, S. Demarest, E. Langley, 2010, Molecular Cancer Therapeutics.

Characterization of Inhibitory Anti-insulin-like Growth Factor Receptor Antibodies with Different Epitope Specificity and Ligand-blocking Properties

Christilyn P. Graff, Xiufeng Wu, A. Sereno, 2009, Journal of Biological Chemistry.

Anti-sexual and anxiogenic behavioral consequences of corticotropin-releasing factor overexpression are centrally mediated

S. Heinrichs, W. Vale, S. Boehme, 1997, Psychoneuroendocrinology.

The integrin VLA-4 mediates leukocyte recruitment to skin inflammatory sites in vivo.

M. Elices, V. Tollefson, S. Tamraz, 1993, Clinical and experimental rheumatology.